Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Greece, Slashing Drug Budget Via Cuts And Non-Payment, Backs Generics

Executive Summary

Greece has slashed its pharmaceutical budget in half by price cuts and withholding payments, but it is now turning to generics to fulfill its citizens’ health care needs.

You may also be interested in...



EU Pricing Pressures On Generics And Biosimilars Risk Killing Industry –EGA Execs

New EGA president and director general say Europe must end downward pricing pressures on generic medicines manufacturers or risk losing that industry altogether.

German HTA Blueprint Could Be Imposed On Greece

Germany’s role in preparing a health reform agreement between Greece and the World Health Organization may lead to a G-BA/IQWiG-style HTA process being introduced in the Hellenic Republic.

Roche Suspends Medicines Deliveries To Indebted Greek Hospitals

Mired in economic troubles, Greece's public hospitals owe the drug maker more than €150 million. The health ministry says it is sending cash soon.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

LL1134044

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel